- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06532266
Randomised Controlled Trial on Using Active Warming to Prevent Newborn Hypothermia After Caesarean Delivery
A Randomised Controlled Trial Using Active Warming in Prevention of Newborn Hypothermia After Caesarean Delivery Without Interruption to Skin-to-skin Contact
Despite the enormous advantages that skin-to-skin contact (STSC) and Delaying Cord Clamping (DCC) bring, newborns can lose heat quickly if they are not thermally protected. In the first 10-20 minutes after birth, newborns can experience a body temperature drop of between 2°C to 4°C if they are not properly dried and covered. In 2014, Horn et al. published a research paper regarding the incidence and prevention of newborn hypothermia after Caesarean delivery. The findings showed up to 80% of newborns become hypothermic if only warm towels (passive insulation) were used during STSC after Caesarean delivery. Evidence also shows higher hypothermia rates in infants born by Caesarean section than vaginal birth.
STSC will begin while Caesarean section continues. Newborns will be clothed in a cotton hat and diaper. Newborns will be placed on bare chest of mother, horizontally, in prone position. The head of the newborn will turn laterally, making the nose and mouth unobstructed. Newborns' hands are not swaddled and are free to move to allow exploration to facilitate first feeding. In both groups, infants will be covered from head-to-toe with 3 layers of 100% cotton woven blankets, taken from a 70°C heating cabinet. For the "intervention group", thermal blanket will be placed on top of the cotton blanket. Newborn will be first covered with conventional warm blanket then adding the thermal blanket on top. The thermal blanket will be placed inside a "pillowcase" like cotton blanket to avoid direct contact with mother or newborn.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ka Wang Cheung, MD
- Phone Number: 22554567
- Email: kelvincheung82@hotmail.com
Study Locations
-
-
Hong Kong
-
Hong Kong, Hong Kong, China, 852
- Recruiting
- Department of Obstetrics and Gynaecology
-
Contact:
- Ka Wang Cheung
- Phone Number: (852) 22553111
- Email: kelvincheung82@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All women scheduled for elective Caesarean section under spinal anaesthesia during study period.
Exclusion Criteria:
- Multiple pregnancy
- Gestation <37week or >42 week
- Placenta previa or abruptio placenta
- Abnormal Cardiotocogram or fetal heart rate immediately prior to Caesarean section
- Suspected or known fetal congenital abnormality
Immediate newborn condition that prevents STSC
- Newborn birth weight <2.5kg
- Newborn rectal temperature >38°C
- Maternal tympanic temperature >38°C
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
|
3 layers of 100% cotton woven blankets
|
|
Active Comparator: Intervention
|
The thermal blanket will be placed on top of the cotton blanket.
Newborn will be first covered with conventional warm blanket then adding the thermal blanket on top.
The thermal blanket will be placed inside a "pillowcase" like cotton blanket to avoid direct contact with mother or newborn.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Newborn hypothermia
Time Frame: after 20 minutes of skin to skin contact after Caesarean delivery or at the cessation of using active or conventional warming method before completion of 20 minutes of STSC, whichever happens first.
|
Body temperature below 36.5°C
|
after 20 minutes of skin to skin contact after Caesarean delivery or at the cessation of using active or conventional warming method before completion of 20 minutes of STSC, whichever happens first.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ka Wang Cheung, MD, The University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW 22-695
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Newborn; Hyperthermia
-
Instituto de Investigación Hospital Universitario...Universidad Autonoma de MadridRecruiting
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.CompletedThermotherapy | Therapeutic Hyperthermia | PolymersBrazil
-
Ankara City Hospital BilkentCompletedChildhood Cancer | Hypothermia; Anesthesia | Radiotherapy Side Effect | Hyperthermia, Anesthesia RelatedTurkey
-
West China HospitalRecruiting
-
Brno University HospitalMasaryk UniversityCompleted
-
Children's Hospital Medical Center, CincinnatiTerminated
-
Peking University Third HospitalRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Universidade do PortoNot yet recruitingExercise Induced Hyperthermia | Performance Demands of Exercising in the Heat
-
Children's Hospital Medical Center, CincinnatiWithdrawnMalignant HyperthermiaUnited States